Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Gynecologic Oncology Reports|July 7, 2018
Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case reportChanhee Han, Stefania Bellone, Peter E Schwartz, et al.
Cancer Discovery|October 27, 2022
Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti-PD-1 Immunotherapy in Endometrial CarcinomaRyan D Chow, Tai Michaels, Stefania Bellone, et al.
Gynecologic Oncology Reports|March 7, 2020
Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinomaSilvia Pelligra, Natalia Buza, Pei Hui, et al.
Gynecologic Oncology|April 26, 2003
Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervixAlessandro D Santin, Stefania Bellone, Michela Palmieri, et al.
Biochemical and Biophysical Research Communications|December 26, 2006
Immunogenic gangliosides in human ovarian carcinomaMepur H Ravindranath, Sakunthala Muthugounder, Naftali Presser, et al.
Gynecologic Oncology Reports|June 29, 2026
Activity of datopotamab deruxtecan in TROP2-expressing low-grade serous ovarian cancer: a preclinical studySarah Ottum, Orazio De Tommasi, Cem Demirkiran, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10Alessandro D Santin, Stefania Bellone, Michela Palmieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancerAlessandro D Santin, Eleftherios P Diamandis, Stefania Bellone, et al.
Gynecologic Oncology|May 21, 2005
High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancerStefania Bellone, Katherine Watts, Stefania Cane', et al.
Gynecologic Oncology|September 4, 2025
Effective preclinical activity of datopotamab deruxtecan (Dato-DXd), an ADC targeting trophoblast cell-surface antigen 2 (TROP2), against primary cervical carcinoma cell lines and xenograftsVictoria M Ettorre, Cem Demirkiran, Stefania Bellone, et al.
Pageof 17